Research Tavneos trial flagged for ‘serious breaches’ of protocol as EU regulators dissect market withdrawal decisionBy Healthcare Propulsion StaffAugust 14, 20260 With the European Union formally reversing its marketing authorization for rare disease med Tavneos last week, regulators from the bloc…
